News
Telehealth suicide prevention program safe, acceptable
Study participants reported the program was convenient and noted that it decreased the burden of traveling to sessions.
News
Melatonin: A new way to reduce self-harm?
Melatonin may reduce the risk of self-harm by treating sleep problems related to psychiatric comorbidities, especially anxiety and depression.
News
Safety, efficacy of analgesics for low back pain ‘uncertain’
“When we set out to do this review, we envisioned the evidence would be a lot more comprehensive.”
News
Physical activity is a growing priority for patients with MS
Recent research suggests that exercise may benefit patients with MS.
News
New digital tools hold promise for patients with MS
High-tech tools currently in development can detect not only motor and visual dysfunction but also cognitive dysfunction.
News
Cutting calories may benefit cognition in MS
For patients with MS, cognition can be positively influenced by healthy dietary habits.
News
High level of psychiatric morbidity in prodromal MS
The relative risk of psychiatric morbidity was up to 88% higher in patients with MS, compared with their counterparts without the disease.
News
CBT alone and with meds may decrease MS fatigue
“Clinicians should consider clinical characteristics and overall treatment goals when selecting fatigue interventions, to offer a more...
News
Endovascular therapy benefits large infarction: ANGEL-ASPECT
Trial stopped early because a planned interim analysis showed efficacy of endovascular therapy.
News
Tenecteplase noninferior to alteplase for ischemic stroke: TRACE-2
“The results provide further evidence to support a worldwide switch to tenecteplase as the preferred thrombolytic for acute ischemic stroke.”
News
Blood pressure lowering after thrombectomy may be harmful
Using an antihypertensive drug to target systolic blood pressure to below 160 mm Hg or 140 mm Hg after thrombectomy may not be beneficial.
News
Novel neuroprotective agent promising in stroke
New findings illustrate that it is possible to improve outcomes for stroke patients “not only with reperfusion therapy but with neuroprotectants...
News
Sleep abnormalities common in all stages of psychosis
Clinicians should screen for insomnia in early-course patients and perhaps recommend cognitive behavioral therapy for insomnia.
News
Biosimilar equal to natalizumab for relapsing remitting MS
Biosim-NTZ is the first biosimilar monoclonal antibody therapy to be developed for MS.
News
Even one head injury boosts all-cause mortality risk
The findings of a new study underscore the importance of preventing head injuries and of swift clinical intervention once a head injury occurs,...